非肝硬化性门静脉高压症的临床管理现状  

Current status of the clinical management of non-cirrhotic portal hypertension

作　　者：徐京杭[1] 于岩岩[1] 徐小元[1] XU Jinghang;YU Yanyan;XU Xiaoyuan(Department of Infectious Diseases,Peking University First Hospital,Beijing 100034,China)

机构地区：[1]北京大学第一医院感染疾病科,北京100034

出　　处：《临床肝胆病杂志》2022年第7期1457-1459,共3页Journal of Clinical Hepatology

基　　金：国家科技重大专项(2017ZX10202202)。

摘　　要：非肝硬化性门静脉高压症并非罕见,其临床管理策略有别于肝硬化性门静脉高压症。按照发病机制和病因的不同,可分为肝前性、肝性和肝后性门静脉高压症,其中肝性可进一步分为窦前性、窦性和窦后性。结合临床表现、影像学与病理学检查及时诊断,并启动相应治疗是临床管理的关键。然而本组疾病异质性强,不易诊断,亟需临床工作者提高对本组疾病的认识,以期提高临床管理水平。Non-cirrhotic portal hypertension(NCPH)is not uncommon,and its clinical management strategies are different from those for cirrhotic portal hypertension.According to pathogenesis and etiology,NCPH can be classified into prehepatic,hepatic,and posthepatic NCPH,among which hepatic NCPH can be further classified into presinusoidal,sinusoidal,and postsinusoidal NCPH.Timely diagnosis based on clinical manifestation,radiological examination,and pathology and initiation of corresponding treatment are the key to the clinical management of NCPH.However,the diseases in this group are highly heterogeneous and difficult to diagnose,and it is urgent for clinicians to improve their understanding of such diseases,so as to improve the level of clinical management.

关 键 词：非肝硬化性门静脉高压 诊断 治疗学 

分 类 号：R575.2[医药卫生—消化系统]